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In this issue of Gut, Farro et al and Pohl et al present new findings on the role of 
myeloid cells in postoperative ileus (POI).1 2 
POI is a frequent consequence of abdominal surgery that can lead to costly delays in 
patient recovery.3 The failure of peristalsis reflects paralysis of the smooth muscles 
of the intestine and several studies have suggested that this is dependent on 
macrophages in the muscularis externa (ME) layer of the gut wall that produce nitric 
oxide (NO).4 
The intestine contains one of the largest pools of macrophages in the body, the 
majority of which is located in the lamina propria (LP) of the mucosa, near the 
epithelium. However macrophages are also present between the longitudinal and 
circular muscle layers of the ME, where they are in close proximity to the myenteric 
plexus.5 6 Recent studies indicate that LP and ME macrophages are phenotypically 
and functionally distinct under steady-state conditions.6 In particular, ME 
macrophages appear to have specialised tissue protection functions, including the 
production of factors such as bone morphogenic protein-2 (BMP2) that promote 
neuronal growth. In return, β2-adrenergic receptors on ME macrophages allow them 
to be sustained by sympathetic neurons and these two-way interactions are at least 
partly dependent on the local microbiota.6 
Mechanical insults such as abdominal surgery disrupt this steady-state balance, 
causing smooth muscle paralysis and infiltration of the small intestinal ME with 
blood-derived monocytes, mast cells and neutrophils. Studies in experimental 
animals have shown that POI is dependent on production of NO and other mediators 
by these myeloid cells and can be prevented by depleting cells of the monocyte-
macrophage lineage in vivo.4 7 8 Using mice with a selective defect in blood 
monocytes caused by deletion of the CCR2 chemokine receptor, Pohl et al and 
Farro et al now examine whether these effects are due to changes in the existing 
population of resident ME macrophages, or to the monocytes that have been 
recruited from the bloodstream.1 2These studies show that elicited monocytes are 
critical for producing NO and initiating POI in both the small intestine and colon, but 
there are important differences between these tissues in the mechanisms involved. 
First, resident ME macrophages can also contribute to POI in the small intestine, 
perhaps being activated directly by products of the local microbiota that have leaked 
through the mechanically damaged intestinal barrier.1 This does not occur in the 
colon, where the authors suggest that resident macrophages have been rendered 
unresponsive by the larger load of microbiota in this site. The second difference is 
that POI in the small intestine is dependent on dendritic cells (DCs) that express both 
CD103 and CD11b, a population that is unique to the intestine. These DCs produce 
interleukin 12 which stimulates T cells to make γ-interferon that then drives NO 
production by monocytes. Although monocytes in the colon also produce NO, 
CD103+CD11b+DCs are much less numerous here and it appears that the colonic 
monocytes may be stimulated directly by the local microbiota.2Understanding these 
anatomical differences has therapeutic implications, as the small intestine is the 
main target of POI and as the current papers show, interfering with elicited 
monocytes and resident macrophages requires different approaches. 
Although both studies conclude that elicited monocytes are critical for the initiation of 
POI, Farro et al show that these cells have opposite effects during the resolution of 
POI, when they gradually acquire the features of tissue-protective 
macrophages.1 Indeed this protective function may be the principal role of elicited 
monocytes in POI, as monocyte/macrophage depletion leads to enhanced 
pathology, increased neuronal damage and a delay in recovery. Although the 
authors suggest that some of the protective effects may be due to pre-existing 
resident macrophages, Janus-like behaviour of elicited monocytes of this kind has 
been shown recently in other models of inflammation, where they can give rise to 
mature, protective macrophages, or can themselves have anti-inflammatory 
roles.9 For instance, production of prostaglandin E2 (PGE2) by monocytes prevents 
immunopathology in experimental intestinal toxoplasmosis by inhibiting the 
recruitment and activation of pathogenic neutrophils.10 Neutrophils are a major 
component of the inflammatory infiltrate of POI and their numbers are sustained after 
depletion of monocytes. As they produce NO, reactive oxygen species and other 
potentially neurotoxic mediators,  it seems quite possible that neutrophils may be the 
major player in the pathological features of POI. It would be interesting to explore the 
role of monocyte-derived PGE2 in recovery from POI. 
Taken together, these studies suggest that targeting elicited monocytes could have 
therapeutic potential in modulating POI. Indeed, Farro et al show that administration 
of the monocyte-macrophage specific growth factor colony stimulating factor-1 (can 
promote resolution of experimental POI,1 an approach that has also proved 
successful in preclinical studies of liver injury.11 For this idea to be realised, it would 
clearly be important to confirm that the pathogenetic processes outlined in mice 
extend to humans, something that will require the development of suitable 
biomarkers that allow POI and monocyte recruitment to be monitored. At a more 
fundamental level, the reasons underlying the opposing effects of monocytes at 
different stages of POI need to be explored. For instance, do the reparative 
properties reflect the arrival of a new wave of monocytes that differ from those that 
are proinflammatory in the initiation phase and if so, do the different populations of 
monocytes show distinct phenotypical features or chemokine receptor requirements 
that might be exploitable for intervention? On the other hand, if the monocytes that 
arrive early in POI truly differentiate in situ and normally become protective, what 
drives this transition, is it defective in patients who suffer prolonged symptoms and 
can it be accelerated therapeutically? Although it is generally believed that elicited 
monocytes cannot give rise to long-lived resident macrophages in an inflammatory 
environment, this idea has recently been challenged12 and in the case of a normally 
transient condition such as POI, permanent engraftment of reprogrammed 
monocytes may not be necessary. Finally, the mechanisms responsible for activating 
the DCs, monocytes and macrophages in POI remain to be determined. If a role for 
the microbiota and/or individual bacterial species can be identified, the prospect of 
tailoring preoperative antibiotic use or even addition of probiotics might become a 
realistic option for preventing POI. 
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